Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys-Reference-Cited by-同舟云学术

Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys

Published:2019-01 Issue:1 Volume:24 Page:256-262
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Yaribeygi Habib,Katsiki Niki,Butler Alexandra E.,Sahebkar Amirhossein

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference63 articles.

1. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy;Navarro-González;Nat. Rev. Nephrol.,2011

2. Oxidative stress induces renal failure: a review of possible molecular pathways;Yaribeygi;J. Cell. Biochem.,2018

3. Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy;Yaribeygi;J. Cell. Biochem.,2018

4. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy;Yaribeygi;J. Cell. Biochem.,2018

5. Signaling cascades and inflammasome activation in microbial infections;Ali;Inflammasome,2016

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inibidores de SGLT2 e inflamassoma NLRP3: alvo potencial na doença renal do diabetes;Brazilian Journal of Nephrology;2024-12

2. SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease;Brazilian Journal of Nephrology;2024-12

3. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

4. Glp-1 Mimetics and Autophagy in Diabetic Milieu: State-of-the-Art;Current Diabetes Reviews;2024-10

5. GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-22